Roche Holding AG
Bear Case (25th pct.)
-22.7% vs price
Base Case (Median)
37.2% vs price
Bull Case (75th pct.)
47.8% vs price
◇ = Current price | |Bear |Base | Bull
| Method | Est. Value | vs Price | Weight |
|---|---|---|---|
| DCF (Discounted Cash Flow) | $580.64 | 37.2% | High (40%) |
| PE Comparable | $601.09 | 42.0% | Medium (25%) |
| Growth Trajectory DCF | $649.79 | 53.5% | Medium (20%) |
| Graham Number | $160.68 | -62.0% | Medium (40%) |
| EV/EBITDA | $284.77 | -32.7% | Medium (20%) |
| EV/FCF | $661.81 | 56.4% | Medium (20%) |
| Earnings Power Value | $369.87 | -12.6% | Medium (50%) |
Based on 7 out of 8 methods, RHHBF appears fairly valued at the current price of $423.20. The base case fair value of $580.64 implies 37.2% upside.
Bear/base/bull cases represent the 25th, 50th, and 75th percentile of available method estimates. This is not financial advice. Valuation is inherently uncertain.